XBiotech Patents – Insights & Stats (Updated 2023)

XBiotech has a total of 357 patents globally, out of which 152 have been granted. Of these 357 patents, more than 76% patents are active. The United States is where XBiotech has filed the maximum number of patents, followed by China. Parallelly, the US seems to be the main focused R&D center of XBiotech and is also the origin country of the firm.

XBiotech was founded in the year 2005 by John Simard. The company is a biopharmaceutical firm developing antibody therapies.

Do read about some of the most popular patents of XBiotech which have been covered by us in this article and also you can find XBiotech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over XBiotech patent portfolio.

How many patents does XBiotech have?

XBiotech has a total of 357 patents globally. These patents belong to 80 unique patent families. Out of 357 patents, 274 patents are active.

How Many Patents did XBiotech File Every Year?

XBiotech Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantXBiotech Applications FiledXBiotech Patents Granted
2022510
20212611
20201818
20191320
20181424
20171018
20161716
2015308
2014117
2013282
2012458
2011404

How many XBiotech patents are Alive/Dead?

Worldwide Patents

XBiotech Patent Portfolio

How Many Patents did XBiotech File in Different Countries?

XBiotech Worldwide Patent Filing

List of Countries in which XBiotech Filed Patents

CountryPatents
United States Of America33
China33
Korea (South)29
Europe29
Japan26
Australia26
Canada22
Hong Kong (S.A.R.)22
Israel17
Spain10
Russia10
Mexico10
Philippines8
Singapore7
Denmark7
South Africa6
Portugal6
India5
Indonesia4
New Zealand4
Turkey3
Malaysia3
Austria3
Chile2
Poland2
Brazil2
Slovenia2
Colombia1
Germany1
Cyprus1
Hungary1

Where are Research Centres of XBiotech Patents Located?

R&D Centres of XBiotech

10 Best XBiotech Patents

US20100040574A1 is the most popular patent in the XBiotech portfolio. It has received 40 citations so far from companies like Janssen Biotech.

Below is the list of 10 most cited patents of XBiotech:

Publication NumberCitation Count
US20100040574A140
US9486523B216
US9416172B214
US20110071054A114
WO2007015128A114
US20090191149A112
US20110071276A111
US20110008282A19
US20110070229A17
WO2014055541A17

What are XBiotech’s key innovation segments?

What Technologies are Covered by XBiotech?

The chart below distributes patents filed by XBiotech in different countries on the basis of the technology protected in patents. It also represents the markets where XBiotech thinks it’s important to protect particular technology inventions.

R&D Focus: How has XBiotech’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by XBiotech?

Related Articles

Luzerne Patents – Insights & Stats (Updated 2024)

Luzerne has a total of 9 patents globally, out of which all patents have been granted. Of these 9 patents, all patents are active. Singapore is where Luzerne has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the origin

Read More »

Garena Patents – Insights & Stats (Updated 2024)

Garena has a total of 96 patents globally, out of which 15 have been granted. Of these 96 patents, more than 80% patents are active. Singapore is where Garena has filed the maximum number of patents, followed by United States of America and China. Parallelly, Singapore seems to be the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.